These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The actual incidence of papaverine-induced priapism in patients with erectile dysfunction following penile colour Doppler ultrasonography. Kilic M; Serefoglu EC; Ozdemir AT; Balbay MD Andrologia; 2010 Feb; 42(1):1-4. PubMed ID: 20078509 [TBL] [Abstract][Full Text] [Related]
7. The incidence and management of priapism in Western Australia: a 16 year audit. Earle CM; Stuckey BG; Ching HL; Wisniewski ZS Int J Impot Res; 2003 Aug; 15(4):272-6. PubMed ID: 12934055 [TBL] [Abstract][Full Text] [Related]
8. Continuous infusion of phenylephrine in the treatment of papaverine-induced priapism. Buckley JF; Chapple CR; McNicholas T Br J Urol; 1989 Dec; 64(6):654-5. PubMed ID: 2627645 [No Abstract] [Full Text] [Related]
9. Chart for preparation of dilutions of alpha-adrenergic agonists for intracavernous use in treatment of priapism. Lee M; Cannon B; Sharifi R J Urol; 1995 Apr; 153(4):1182-3. PubMed ID: 7869493 [TBL] [Abstract][Full Text] [Related]
10. Effects of priapism lasting 24 hours or longer caused by intracavernosal injection of vasoactive drugs. Kulmala RV; Tamella TL Int J Impot Res; 1995 Jun; 7(2):131-6. PubMed ID: 7496442 [TBL] [Abstract][Full Text] [Related]
11. Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. Vapnek J; Lue TF J Urol; 1989 Nov; 142(5):1323-4. PubMed ID: 2509734 [TBL] [Abstract][Full Text] [Related]
12. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762 [TBL] [Abstract][Full Text] [Related]
13. [Priapism as a complication of the treatment of impotence by local injections of papaverine]. Kaczmarek A Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150 [TBL] [Abstract][Full Text] [Related]
15. Treatment of pharmacological priapism with phenylephrine. Dittrich A; Albrecht K; Bar-Moshe O; Vandendris M J Urol; 1991 Aug; 146(2):323-4. PubMed ID: 1856926 [TBL] [Abstract][Full Text] [Related]
16. Comparison of one-side and bilateral intracavernosal papaverine injection on a Doppler study of the penis. Ghafoori M; Hoseini K; Shakiba M Int J Impot Res; 2009; 21(6):382-6. PubMed ID: 19847184 [TBL] [Abstract][Full Text] [Related]
17. Independent Predictive Factors for Occurrence of Ischemic Priapism after Papaverine Injection. Güler Y; Erbin A Urol J; 2020 May; 17(5):512-516. PubMed ID: 32478401 [TBL] [Abstract][Full Text] [Related]
18. A lethal complication of papaverine-induced priapism. Hashmat AI; Abrahams J; Fani K; Nostrand I J Urol; 1991 Jan; 145(1):146-7. PubMed ID: 1984077 [TBL] [Abstract][Full Text] [Related]
19. Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction. Hübler J; Szántó A; Könyves K Int Urol Nephrol; 2003; 35(4):519-21. PubMed ID: 15198160 [TBL] [Abstract][Full Text] [Related]
20. Intracorporeal phenylephrine reduces thioridazine (Mellaril) induced priapism in a child. Siegel JF; Reda E J Urol; 1997 Feb; 157(2):648. PubMed ID: 8996390 [No Abstract] [Full Text] [Related] [Next] [New Search]